Skip to main content
Premium Trial:

Request an Annual Quote

David Mott, Joseph Trepanier III, Gov. Janet Napolitano, Rod Wing, Michael Cusanovich, Margaret Wilch

Premium
Former MedImmune President/CEO Joins Venture Capital Firm as General Partner
 
David Mott, the former president and CEO of MedImmune, has joined the venture capital firm New Enterprise Associates as general partner.
 
Mott will focus on biotechnology and specialty pharmaceutical investing within the east coast healthcare practice of NEA. Founded in 1978, NEA has US offices in Chevy Chase, Md.; Menlo Park, Calif.; and Baltimore; as well as overseas offices in Bangalore, India; and the Chinese cities of Beijing and Shanghai.
 
Mott left MedImmune within months of the company’s acquisition last year by AstraZeneca for $15.6 billion. After the deal was completed, Mott was named an executive vice president of AZ, and continued to chair the acquired company’s venture capital subsidiary MedImmune Ventures, which he founded in 2002. Mott’s departure capped a 15-year career at MedImmune, during which time he served in roles of increasing responsibility — including chief operating officer and chief financial officer — before being named president/CEO.
 
Before joining MedImmune, Mott was a vice president in the healthcare investment banking group at Smith Barney Harris Upham & Company Inc. Mott's activities included public and private equity and debt financings as well as merger and acquisition work for biotechnology, healthcare services, and medical product and device companies.
 
Mott is currently a director of pharmaceutical company Shire, and of antibiotic company Rib-X Pharmaceuticals. He is a member of the Management Executives' Society and the St. Albans School Governing Board, and a senior advisor to Chatham House, the London-based international and economic affairs institution.
 
Mott holds a bachelor's degree in economics and government from Dartmouth College.
 

 
Morrisville, NC, Clinical Trial Management Software Firm Names Secretary/CFO
Joseph Trepanier III has been named permanent secretary and chief financial officer of etrials Worldwide, a provider of software and services used by pharmaceutical, biotechnology, medical device, and contract research organizations in clinical trial management. Trepanier has served since May as interim secretary and chief financial officer, and had previously been etrials’ corporate controller and vice president of finance.
 
Prior to joining etrials earlier this year, Trepanier held positions as chief operating officer with Durham, NC-based SmartOnline, as chief finance officer/chief operating officer at DataFlux, and director of finance at Hill-Room. Trepanier is a licensed certified public accountant in North Carolina.
 
Trepanier holds an MBA from the Southern New Hampshire University, a BS in accounting from West Virginia University, and a BS from the University of New Hampshire.
 

 
Arizona’s Gov. Napolitano, Three Educators Honored by AzBio
 
Gov. Janet Napolitano of Arizona and three educators were among honorees of the Arizona Bioindustry Association, the state’s life sciences industry group, at its annual dinner, held Sept. 18 at the Buttes, a Marriott resort in Tempe, Ariz.
 
Napolitano, a Democrat in her second term, won the Public Service Award for current or former elected officials who have “demonstrated leadership that has contributed most significantly to the enhancement of the business climate for bioscience companies in the state,” according to AZBio.
 
Also honored by AZBio were two University of Arizona faculty members, and a Tucson, Ariz., science teacher with close ties to UA:
  • Rod Wing, director of the Arizona Genomics Institute, won the Award for Research Excellence, given to life science researchers in Arizona who have made the most significant contribution to the advancement of knowledge and the understanding of biological processes, “as measured by publications and/or professional acknowledgement of their work in either an academic or commercial setting,” according to AZBio.

    Wing, who is also the Bud Antle Endowed Chair for Excellence in Agriculture and Life Sciences and a member of the BIO5 Institute, has focused on mapping the genomic structures of rice and corn. Wing has collaborated with scientists in China and the Philippines to improve crop strains.

  • Michael Cusanovich, UA Regents' professor in biochemistry and molecular biophysics, won the Jon W. McGarity Leadership Award, presented to the most outstanding leadership that contributed significantly to development of the state’s bioindustry and/or recognition of the advancement of bioscience in Arizona. A former UA vice president for research, Cusanovich is director of the Arizona Research Laboratories, an umbrella research organization for the Center for Insect Sciences, the McKnight Brain Institute, the Institute for the Study of Planet Earth, and the Neural Systems, Memory and Aging group.

  • Margaret Wilch, a teacher in the Tucson Unified School District, won AZBio’s Bioscience Educator of the Year award, bestowed on K-12 teachers. Wilch, a biology teacher at Tucson High Magnet School, has collaborated with the UA's BIO5 Institute and College of Science faculty. She joined with UA Regents' Professor Nancy Moran to develop the Biotechnology Laboratory for Arizona Students and Teachers, or BLAST. BLAST offers summer training in biotechnology for students and teachers, and is used by Tucson High students during the school year.
Other AZBio honorees were Dedicated Phase I, a clinical trial site for pharmaceutical development companies that received the Fast Start Award; and Provista Life Sciences, a Phoenix business honored as Bioscience Company of the Year for a new diagnostic blood test designed for the early detection of breast cancer.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.